171 related articles for article (PubMed ID: 14650885)
1. Ubiquitinylation and proteasome-dependent degradation of the phosphoinositide-specific phospholipase C gamma 1 in A-431 cells.
Evdonin AL; Tsupkina NV; Nikol'skii NN; Medvedeva ND
Dokl Biol Sci; 2003; 392():456-7. PubMed ID: 14650885
[No Abstract] [Full Text] [Related]
2. [Effect of EGF on ubiquitination and proteasome-dependent degradation of phospholipase C gamma1 in A431 cells].
Evdonin AL; Tsupkina NV; Nikol'skiĭ NN; Medvedeva ND
Tsitologiia; 2003; 45(10):1013-8. PubMed ID: 14989173
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies.
Longva KE; Blystad FD; Stang E; Larsen AM; Johannessen LE; Madshus IH
J Cell Biol; 2002 Mar; 156(5):843-54. PubMed ID: 11864992
[TBL] [Abstract][Full Text] [Related]
4. cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors.
Ettenberg SA; Rubinstein YR; Banerjee P; Nau MM; Keane MM; Lipkowitz S
Mol Cell Biol Res Commun; 1999 Aug; 2(2):111-8. PubMed ID: 10542134
[TBL] [Abstract][Full Text] [Related]
5. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7.
Yokouchi M; Kondo T; Houghton A; Bartkiewicz M; Horne WC; Zhang H; Yoshimura A; Baron R
J Biol Chem; 1999 Oct; 274(44):31707-12. PubMed ID: 10531381
[TBL] [Abstract][Full Text] [Related]
6. Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival.
Lee G; Junn E; Tanaka M; Kim YM; Mouradian MM
J Neurochem; 2002 Oct; 83(2):346-52. PubMed ID: 12423244
[TBL] [Abstract][Full Text] [Related]
7. Lactacystin, proteasome function, and cell fate.
Fenteany G; Schreiber SL
J Biol Chem; 1998 Apr; 273(15):8545-8. PubMed ID: 9535824
[No Abstract] [Full Text] [Related]
8. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
[TBL] [Abstract][Full Text] [Related]
9. C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation.
Cardozo CP; Michaud C; Ost MC; Fliss AE; Yang E; Patterson C; Hall SJ; Caplan AJ
Arch Biochem Biophys; 2003 Feb; 410(1):134-40. PubMed ID: 12559985
[TBL] [Abstract][Full Text] [Related]
10. Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway.
Folco EJ; Koren G
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):37-43. PubMed ID: 9359831
[TBL] [Abstract][Full Text] [Related]
11. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation.
Magnifico A; Ettenberg S; Yang C; Mariano J; Tiwari S; Fang S; Lipkowitz S; Weissman AM
J Biol Chem; 2003 Oct; 278(44):43169-77. PubMed ID: 12907674
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells.
Murray EJ; Bentley GV; Grisanti MS; Murray SS
Exp Cell Res; 1998 Aug; 242(2):460-9. PubMed ID: 9683533
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of phosphorylated neurofilaments and increase in apoptosis-specific protein and phosphorylated c-Jun induced by proteasome inhibitors.
Masaki R; Saito T; Yamada K; Ohtani-Kaneko R
J Neurosci Res; 2000 Oct; 62(1):75-83. PubMed ID: 11002289
[TBL] [Abstract][Full Text] [Related]
15. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin.
Li XY; Boudjelal M; Xiao JH; Peng ZH; Asuru A; Kang S; Fisher GJ; Voorhees JJ
Mol Endocrinol; 1999 Oct; 13(10):1686-94. PubMed ID: 10517670
[TBL] [Abstract][Full Text] [Related]
17. Cell adhesion protects c-Raf-1 against ubiquitin-dependent degradation by the proteasome.
Manenti S; Delmas C; Darbon JM
Biochem Biophys Res Commun; 2002 Jun; 294(5):976-80. PubMed ID: 12074572
[TBL] [Abstract][Full Text] [Related]
18. Proteasome-dependent degradation of oxidized proteins in MRC-5 fibroblasts.
Sitte N; Merker K; Grune T
FEBS Lett; 1998 Dec; 440(3):399-402. PubMed ID: 9872410
[TBL] [Abstract][Full Text] [Related]
19. hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl.
Hall AB; Jura N; DaSilva J; Jang YJ; Gong D; Bar-Sagi D
Curr Biol; 2003 Feb; 13(4):308-14. PubMed ID: 12593796
[TBL] [Abstract][Full Text] [Related]
20. Proteasomal degradation of tau protein.
David DC; Layfield R; Serpell L; Narain Y; Goedert M; Spillantini MG
J Neurochem; 2002 Oct; 83(1):176-85. PubMed ID: 12358741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]